肝内胆管癌根治性切除术后淋巴结转移的危险因素及预后价值
该回顾性病例系列研究纳入230例在北京大学人民医院接受首次根治性肝切除并经病理确诊的肝内胆管癌(ICC)患者,旨在探讨术后淋巴结转移的危险因素。多因素Logistic回归显示癌胚抗原>4.7 μg/L、术前影像学淋巴结肿大及大胆管型组织学亚型为独立危险因素。淋巴结转移与缩短的OS和RFS相关,淋巴结阳性患者可能从清扫≥6枚淋巴结及术后辅助治疗中获益。
要点
- 癌胚抗原>4.7 μg/L、术前淋巴结肿大、大胆管型是ICC淋巴结转移独立危险因素。
- 淋巴结转移与更差的OS和RFS相关(P值均<0.01)。
- N1组清扫≥6枚淋巴结延长RFS(P=0.004),N0组过度清扫反而预后更差。
核心结论
- 癌胚抗原升高、术前淋巴结肿大及大胆管型组织学亚型是ICC术后淋巴结转移的独立危险因素。
- 淋巴结转移状态影响预后,淋巴结阳性患者更适合清扫≥6枚淋巴结并从辅助治疗中获益,淋巴结阴性患者不宜过度清扫。
研究设计与样本
- 回顾性病例系列研究,连续纳入2015年1月至2025年9月在北京大学人民医院接受首次根治性肝切除并经病理确诊的ICC患者230例。
- 男性120例(52.2%),女性110例(47.8%);年龄M(IQR)59(14)岁(范围31~83岁)。
- 采用多因素Logistic回归筛选淋巴结转移危险因素,Kaplan-Meier法和Cox比例风险模型评估OS和RFS,基于淋巴结状态(N0、N1、Nx)进行亚组分析,RCS评估LNR与预后的关系。
主要发现
- 230例中144例接受淋巴结清扫,淋巴结转移率为38.9%(56/144)。
- 多因素Logistic回归:癌胚抗原>4.7 μg/L(OR=5.895,P=0.030)、术前影像学淋巴结肿大(OR=11.822,P=0.006)、大胆管型组织学亚型(OR=18.224,P=0.001)为独立危险因素。
- 淋巴结转移与缩短的OS和RFS相关(P值均<0.01)。
- N1组清扫≥6枚淋巴结延长RFS(P=0.004)但不改善OS;N0组清扫<6枚者OS与RFS均优于≥6枚者(P值均<0.05)。
- RCS分析:LNR与RFS呈显著线性关联(P总趋势=0.006),与OS无相关性(P=0.451)。
关键数值与推荐
- 淋巴结转移率38.9%(56/144)。
- 癌胚抗原>4.7 μg/L(OR=5.895,P=0.030)、术前淋巴结肿大(OR=11.822,P=0.006)、大胆管型(OR=18.224,P=0.001)为淋巴结转移独立危险因素。
- N1组清扫≥6枚淋巴结延长RFS(P=0.004);N0组清扫<6枚者OS与RFS更优(P值均<0.05)。
- 整体人群辅助治疗改善OS(P=0.039)但不延长RFS(P>0.05);N1组辅助治疗改善OS(P=0.031),N0组改善RFS(P=0.031),Nx组无生存获益(P值均>0.05)。
- LNR与RFS线性关联(P总趋势=0.006),与OS无关联(P=0.451)。
临床怎么用
- 对癌胚抗原>4.7 μg/L、术前影像学淋巴结肿大或大胆管型ICC患者,应警惕淋巴结转移风险。
- 淋巴结阳性患者清扫≥6枚淋巴结可能延长RFS,并可从术后辅助治疗中获益。
- 淋巴结阴性患者应避免过度清扫,辅助治疗主要用于延缓复发。
- Nx组患者未观察到辅助治疗生存获益,需个体化决策。
局限性
- 本研究为单中心回顾性病例系列研究。
- 淋巴结清扫及辅助治疗亚组分析为非随机比较,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate risk factors for postoperative lymph node metastasis in patients with intrahepatic cholangiocarcinoma (ICC) after curative resection. Methods: This retrospective case-series study consecutively enrolled 230 patients who underwent initial curative hepatectomy and were pathologically confirmed as ICC at Peking University People's Hospital between January 2015 and September 2025. The cohort comprised 120 men (52.2%) and 110 women (47.8%), with an age (M(IQR)) of 59 (14) years (range:31 to 83 years). Multivariable logistic regression was performed to identify independent risk factors for lymph node metastasis. Overall survival (OS) and recurrence-free survival (RFS) were evaluated using the Kaplan-Meier method and Cox proportional hazards models. Subgroup analyses based on lymph node status (N0, N1, and Nx) were conducted to explore the impact of lymphadenectomy extent and postoperative adjuvant therapy on prognosis across subgroups. Restricted cubic spline (RCS) analysis was used to assess the association between lymph node ratio (LNR) and survival outcomes. Results: Among the 230 ICC patients, 144 underwent lymphadenectomy, with a lymph node metastasis rate of 38.9% (56/144). Multivariable logistic regression identified carcinoembryonic antigen >4.7 μg/L (OR=5.895, P=0.030), preoperative radiological lymphadenopathy (OR=11.822, P=0.006), and large duct type histological subtype (OR=18.224, P=0.001) as independent risk factors for lymph node metastasis. Survival analyses showed that lymph node metastasis was associated with shortened OS and RFS (both P<0.01). In subgroup analyses of lymphadenectomy, retrieval of ≥6 lymph nodes prolonged RFS in the N1 group (P=0.004) but did not improve OS; in the N0 group, retrieval of <6 lymph nodes was associated with better OS and RFS compared with ≥6 nodes (both P<0.05). RCS analysis demonstrated a significant linear association between LNR and RFS (P=0.006), whereas no association was observed between LNR and OS (P=0.451). Regarding adjuvant therapy, adjuvant treatment improved OS in the overall cohort (P=0.039) but did not prolong RFS (P>0.05). In the N1 group, adjuvant therapy improved OS (P=0.031); in the N0 group, it improved RFS (P=0.031); however, no survival benefit was observed in the Nx group (both P>0.05). Conclusions: Elevated carcinoembryonic antigen, preoperative lymphadenopathy, and large duct type histological subtype are independent risk factors for postoperative lymph node metastasis in ICC. Lymph node status significantly affects prognosis. Patients with lymph node-positive disease may benefit from retrieval of ≥6 lymph nodes and postoperative adjuvant therapy, whereas excessive lymphadenectomy should be avoided in lymph node-negative patients, in whom adjuvant therapy mainly contributes to delaying recurrence. 目的: 探讨肝内胆管癌(ICC)根治性切除患者术后淋巴结转移的危险因素。 方法: 本研究为回顾性病例系列研究。回顾性分析2015年1月至2025年9月在北京大学人民医院接受首次根治性肝切除并经病理学检查确诊为ICC的230例患者的临床、影像学、病理学及随访资料。男性120例(52.2%),女性110例(47.8%);年龄[M(IQR)]59(14)岁(范围:31~83岁)。采用多因素Logistic回归筛选淋巴结转移的独立危险因素;使用Kaplan-Meier法及Cox比例风险模型评估总体生存(OS)和无复发生存(RFS)的影响因素;基于淋巴结状态(N0、N1、Nx)开展亚组分析,探讨淋巴结清扫范围及术后辅助治疗对不同亚组预后的影响;并采用限制性立方样条(RCS)评估淋巴结比率(LNR)与预后的关系。 结果: 230例ICC患者中,144例患者接受淋巴结清扫,淋巴结转移率为38.9%(56/144)。多因素Logistic回归分析结果显示,癌胚抗原>4.7 μg/L(OR=5.895,P=0.030)、术前影像学检查提示淋巴结肿大(OR=11.822,P=0.006)及组织学亚型为大胆管型(OR=18.224,P=0.001)为淋巴结转移的独立危险因素。生存分析结果显示,淋巴结转移会缩短患者的OS时间与RFS时间(P值均<0.01)。淋巴结清扫亚组分析结果显示,在N1组中,清扫≥6枚淋巴结可延长RFS时间(P=0.004),但不改善OS时间;在N0组中,清扫<6枚者的OS与RFS均优于≥6枚者(P值均<0.05)。RCS分析结果显示,LNR与RFS呈显著线性关联(P总趋势=0.006),但与OS无相关性(P=0.451)。根据术后是否行辅助治疗进行分析,结果显示,整体人群中接受辅助治疗可改善OS时间(P=0.039),但不延长RFS时间(P>0.05);在N1组中辅助治疗可改善OS(P=0.031),在N0组中可改善RFS(P=0.031),而在Nx组中未观察到生存获益(P值均>0.05)。 结论: 癌胚抗原升高、术前淋巴结肿大及大胆管型组织学亚型是 ICC术后淋巴结转移的独立危险因素。淋巴结转移状态会影响患者的预后,其中淋巴结转移阳性患者更适合清扫≥6枚淋巴结,并可从术后辅助治疗中获益;淋巴结转移阴性患者不宜过度清扫,辅助治疗的主要作用在于延缓复发。.
引用
- Wei PC, Chen ZMY, Ma DL, et al. [Risk factors and prognostic value of lymph node metastasis in patients undergoing curative resection for intrahepatic cholangiocarcinoma]. Zhonghua Wai Ke Za Zhi. 2026. PMID: 41771524. doi:10.3760/cma.j.cn112139-20251124-00544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。